The PacELF programme: will mass drug administration be enough?
about
Assessment of Climate-sensitive Infectious Diseases in the Federated States of MicronesiaPCR and Mosquito dissection as tools to monitor filarial infection levels following mass treatmentRecombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trialInfection of malaria (Anopheles gambiae s.s.) and filariasis (Culex quinquefasciatus) vectors with the entomopathogenic fungus Metarhizium anisopliaeImpact of two rounds of mass drug administration using diethylcarbamazine combined with albendazole on the prevalence of Brugia timori and of intestinal helminths on Alor Island, IndonesiaInterspecific hybridization yields strategy for South Pacific filariasis vector eliminationGlobal eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmesMale mating competitiveness of a Wolbachia-introgressed Aedes polynesiensis strain under semi-field conditionsOpen release of male mosquitoes infected with a wolbachia biopesticide: field performance and infection containmentReactive oxygen species production and Brugia pahangi survivorship in Aedes polynesiensis with artificial Wolbachia infection typesNo evidence for lymphatic filariasis transmission in big cities affected by conflict related rural-urban migration in Sierra Leone and LiberiaGlobal programme to eliminate lymphatic filariasis: the processes underlying programme success.The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasisDry season production of filariasis and dengue vectors in American Samoa and comparison with wet season productionAssessing the presence of Wuchereria bancrofti in vector and human populations from urban communities in Conakry, Guinea.A critical appraisal of molecular xenomonitoring as a tool for assessing progress toward elimination of Lymphatic Filariasis.A practical strategy for responding to a case of lymphatic filariasis post-elimination in Pacific Islands.Integration of irradiation with cytoplasmic incompatibility to facilitate a lymphatic filariasis vector elimination approach.The impact of insecticide-treated cloth targets on the survival of Stegomyia polynesiensis (= Aedes polynesiensis) under laboratory and semi-field conditions in French Polynesia.Productivity of natural and artificial containers for Aedes polynesiensis and Aedes aegypti in four American Samoan villages.Soluble cellular adhesion molecules, selectins, VEGF and endothelin-1 in patients with Wuchereria bancrofti infection and association with clinical status.Repurposing isoxazoline veterinary drugs for control of vector-borne human diseasesMicrofilaria persistent foci during post MDA and the risk assessment of resurgence in IndiaLymphatic Filariasis in Oceania
P2860
Q24273407-FB5CA6E5-7A26-4158-962A-B5DD65DF2742Q24792371-0B13794D-2575-4266-A5F3-05B2AA337D29Q24795014-3CA12FD5-B1B7-4EE3-870C-060485646656Q24804784-8BAEB388-B8FE-4389-8D47-28074BA90581Q24812360-6589CB6F-543C-4AC8-8FEF-2B1E6D8491F5Q28472111-36394B80-C0BC-4836-9F47-8A901B852ACBQ28473359-AFA15480-971B-4A2B-9DBE-C462E8521336Q28476403-C4A589EE-89B6-450E-A473-3391161908B4Q28485202-E36F3543-7193-4BA4-9FF4-627094BC2F66Q28485517-5588A991-C149-4656-8721-AF075C5B3034Q28539608-C0E25DE7-150E-4179-910B-3E6E5FF3A42BQ30389980-3149EFAE-784A-4FCC-B28E-E3438C5E46F4Q35017384-A7550E29-956A-4FB7-8D8A-17D412A56C35Q36028193-7616C375-A235-4874-ACB4-1824BECC529CQ36094741-043F605D-D120-46B7-A951-07BDC92A94B2Q36377537-5FDF8741-D591-4D13-AC9B-6AC591AD4375Q37053364-44DE2850-BD99-4C59-B685-DB56974D90CBQ37327930-CC893C5E-E3A7-4D12-9BBD-AF96C8D3519CQ38937587-6A56DDBA-CCA3-48C5-8DA4-CC7B243C22FFQ40454781-20444461-02BC-435A-AF58-7E6D96E35A53Q44071632-BC38E165-0620-4224-BD53-D85462352565Q56346104-9C93FCC2-98C7-4C13-9FD6-5294939AD833Q56526350-0C004D66-D9A9-40F2-B55A-5721A8B07F9FQ57043705-DDAB7047-14FA-458A-A880-06BE9EAC1EC2
P2860
The PacELF programme: will mass drug administration be enough?
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The PacELF programme: will mass drug administration be enough?
@ast
The PacELF programme: will mass drug administration be enough?
@en
The PacELF programme: will mass drug administration be enough?
@nl
type
label
The PacELF programme: will mass drug administration be enough?
@ast
The PacELF programme: will mass drug administration be enough?
@en
The PacELF programme: will mass drug administration be enough?
@nl
prefLabel
The PacELF programme: will mass drug administration be enough?
@ast
The PacELF programme: will mass drug administration be enough?
@en
The PacELF programme: will mass drug administration be enough?
@nl
P1476
The PacELF programme: will mass drug administration be enough?
@en
P2093
Kazuyo Ichimori
Tom Burkot
P304
P356
10.1016/S1471-4922(01)02221-8
P577
2002-03-01T00:00:00Z